glp 1 and arthritis Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? glp1 #rheumatology #arthritis #translationalresearch #clinicalresearch

For instance, in April 2025, Pfizer, a US-based pharmaceutical company specializing in metabolic and cardiometabolic drug development, provided an update on its oral GLP-1 receptor agonist candidate, danuglipron, following the completion of once-daily formulation studies intended to improve dosing convenience for patients

But telehealth providers such as Enhance.MD are looking to make the process a little less grueling

These results indicated that daphnetin could attenuate diabetes cognitive dysfunction in rats

This gradual increase allows us to find your 'therapeutic sweet spot'the minimum effective dose that gives you the desired results with the fewest possible side effects

Some peptides may eventually prove useful in specific contexts

1 against teams that are currently below .500, with the only loss being against the Bucks in their last game before the All-Star break